D. KARAKAYA Et Al. , "Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury," NEUROCRITICAL CARE , vol.36, no.3, pp.802-814, 2022
KARAKAYA, D. Et Al. 2022. Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury. NEUROCRITICAL CARE , vol.36, no.3 , 802-814.
KARAKAYA, D., ÇAKIR AKTAŞ, C., UZUN, Ş., Soylemezoglu, F., & MUT AŞKUN, M., (2022). Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury. NEUROCRITICAL CARE , vol.36, no.3, 802-814.
KARAKAYA, DİCLE Et Al. "Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury," NEUROCRITICAL CARE , vol.36, no.3, 802-814, 2022
KARAKAYA, DİCLE Et Al. "Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury." NEUROCRITICAL CARE , vol.36, no.3, pp.802-814, 2022
KARAKAYA, D. Et Al. (2022) . "Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury." NEUROCRITICAL CARE , vol.36, no.3, pp.802-814.
@article{article, author={DİCLE KARAKAYA Et Al. }, title={Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury}, journal={NEUROCRITICAL CARE}, year=2022, pages={802-814} }